Loading market dashboard
Leap Therapeutics, Inc.
LPTXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Leap Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $39.43M | $39.43M - $39.43M | $23.66M | -$0.23 | 1 |
| Dec 2028 | $8.20M | $8.20M - $8.20M | $4.92M | -$0.63 | 1 |
| Dec 2027 | $9.88M | $9.88M - $9.88M | $5.93M | -$0.55 | 1 |
| Dec 2026 | $6.00M | $6.00M - $6.00M | $3.60M | -$0.53 | 1 |
| Dec 2025 | $34.49M | $34.49M - $34.49M | $20.69M | -$1.11 | 1 |
| Dec 2024 | $300.0K | $300.0K - $300.0K | $180.0K | -$1.875 | 2 |
| Dec 2022 | $1.50M | $1.50M - $1.50M | $503.7K | -$4.88 | 1 |
| Dec 2021 | $1.60M | $1.60M - $1.60M | $537.3K | -$4.88 | 1 |
| Dec 2020 | $1.70M | $1.70M - $1.70M | $570.9K | -$6.40 | 1 |